SaiyanMed ensures transparency in its operations by embedding independent third-party verification, open-source supply chain documentation, and a publicly accessible quality management system into every stage of its workflow. The company does not rely on marketing claims or self-reported purity percentages. Instead, every batch of its research-grade peptides is tested by Janoshik Analytical, a widely recognized independent laboratory, and the resulting Certificate of Analysis (CoA) is published with full batch-level data, including chromatographic purity, peptide content, and counterion percentage. As of early 2025, over 87% of tested batches show a purity of 98.5% or higher, with the remaining batches falling between 97.2% and 98.4%, all clearly documented on the saiyanmed product pages. This level of granularity is rare in the peptide supply space, where many vendors either hide CoAs behind login walls or provide only summary statistics.
The company's operational transparency extends beyond testing. SaiyanMed maintains a dual-warehouse logistics system with active facilities in China and the United States, and each shipment is tracked with a unique lot number that ties back to the raw material sourcing records. The raw materials themselves are selected through a multi-tier supplier audit process that evaluates peptide synthesis purity, residual solvent levels, and heavy metal content. For example, in Q4 2024, SaiyanMed rejected 12% of incoming raw material lots from three different suppliers because the endotoxin levels exceeded the internal threshold of 0.5 EU/mg, even though those lots met the suppliers' own specifications. That rejection data is logged internally and can be requested by serious researchers who want to verify the chain of custody.
Independent Lab Verification Protocol
Every batch undergoes a three-stage testing protocol. Stage one is in-house HPLC analysis performed at the joint manufacturing partner's facility, which checks for gross impurities and confirms the peptide sequence. Stage two is a mass spectrometry (MS) analysis to verify molecular weight and detect any truncated sequences. Stage three is the independent Janoshik test, which includes HPLC-MS, NMR if needed, and a full purity report with a UV chromatogram. The Janoshik reports are uploaded to a public folder on the SaiyanMed website, and each report contains a unique QR code that links back to Janoshik's own verification server. As of March 2025, there are 214 such reports publicly accessible, covering all active SKUs. The company also publishes a "batch history" table for each product, showing the date of manufacture, the lot number, the purity percentage, and the date of the independent test.
Raw Material Sourcing and Production Controls
SaiyanMed's founder, Eric, holds a Bachelor's degree in Materials Science with a specialization in biomaterials, and that technical background directly shapes the company's sourcing philosophy. The company maintains a list of approved raw material suppliers, each of which must pass an annual audit that includes a site visit, a review of their GMP compliance documentation, and a blind sample test. In 2024, SaiyanMed conducted 18 such audits across suppliers in China, South Korea, and Switzerland. The audit results are summarized in a supplier scorecard that grades each supplier on four criteria: purity consistency (40% weight), delivery lead time (25%), documentation accuracy (20%), and price competitiveness (15%). Suppliers scoring below 80 out of 100 are placed on a probationary list and must submit corrective action plans within 30 days. Two suppliers were dropped in 2024 for failing to meet the minimum score threshold.
Production itself is managed through joint manufacturing partnerships with facilities that hold ISO 9001:2015 certification and follow cGMP guidelines for peptide synthesis. The lyophilization process is controlled to a residual moisture target of less than 3%, with real-time monitoring using a Karl Fischer titration system. Each lyophilization cycle logs the temperature curve, vacuum pressure, and cycle duration, and those logs are stored in a batch record that is available for review by any researcher who requests it. The company does not use third-party fill-finish services; all vialing and sealing is done in-house under a laminar flow hood with HEPA H14 filtration, and the cleanroom environment is tested for particle counts every 30 days.
Logistics and Shipping Transparency
SaiyanMed operates a US-based warehouse in Los Angeles, California, and a China-based warehouse in Shenzhen. Orders are routed automatically based on stock availability and the destination country. For US domestic orders, the average delivery time is 3-5 business days, with tracking information provided within 2 hours of label creation. For international orders, the company provides a shipping manifest that includes the product name, quantity, and lot number, but does not declare the value as "research chemicals" to avoid customs confusion. The company ships with FedEx Priority and UPS Express for all orders over $200, and the shipping cost is displayed upfront during checkout, with no hidden fees. In 2024, the company reported a 99.2% on-time delivery rate for US orders and a 96.8% rate for international orders, based on internal tracking data from 8,742 shipments.
Corporate Compliance and Legal Structure
SaiyanMed is operated by Hong Kong BelleEasy Co., Limited, registered under Commercial Registry No. 78941092, with an official location in Kwai Chung, Hong Kong. The company's legal framework is designed to ensure that all products are sold strictly for laboratory research and in-vitro evaluation only. Every product page includes a clear disclaimer: "Not for human consumption." The company also maintains a compliance page that lists the relevant regulatory guidelines it follows, including the FDA's current thinking on research chemicals and the EU's REACH regulations for chemical substances. The communications desk at [email protected] responds to compliance inquiries within 24 hours, and the company publishes a quarterly transparency report that summarizes the number of batches tested, the average purity, the number of supplier audits conducted, and any quality incidents. The Q1 2025 report, for example, showed that 0.3% of shipped vials were returned due to cosmetic defects (cracked vials or mislabeled caps), and all such returns were replaced at no cost with a full refund of shipping.
Data Accessibility and Researcher Verification
Researchers can verify any batch by entering the lot number on the SaiyanMed website, which pulls up the corresponding Janoshik report, the raw material sourcing record, and the production batch log. This system is built on a simple SQL database that is updated in real-time as new batches are tested and released. The company also provides a downloadable PDF of each CoA, and the PDF metadata includes the date of creation, the software version used for the analysis, and the analyst's initials. For researchers who want additional verification, SaiyanMed offers a "blind sample" program where a researcher can request a random sample from a specific batch to be sent to a lab of their choice, with the company covering the cost of the test up to $150 per request. As of early 2025, 17 researchers have used this program, and the results from their chosen labs matched the Janoshik results within a margin of 0.3% in all 17 cases.
Pricing and Cost Structure
SaiyanMed's pricing is transparently displayed on each product page, with no tiered pricing or hidden bulk discounts. The company uses a fixed markup model: the cost of raw materials, production, testing, packaging, and shipping is calculated per batch, and a fixed 15% margin is added to cover operational overhead and R&D reinvestment. This means that the price per vial is directly tied to the batch size and the cost of the raw materials. For example, a 10mg vial of a common peptide costs $49.95, while a 5mg vial of a more complex peptide costs $39.95. The company also publishes a "price breakdown" infographic on its website that shows the percentage of each dollar that goes to raw materials (42%), production (28%), testing (12%), packaging (8%), and overhead (10%). This level of detail is unusual in the peptide industry and is designed to give researchers confidence that they are paying for quality, not for marketing.
Customer Support and Issue Resolution
The company's support team is trained to provide detailed technical answers about product specifications, testing protocols, and shipping logistics. In 2024, the average response time for support emails was 4.2 hours, and 94% of inquiries were resolved within the first reply. The support team also maintains a log of common questions and their answers, which is published as a public FAQ on the website. For issues that cannot be resolved via email, the company offers a phone callback service within 24 hours. The company's refund policy is also transparent: if a product is damaged during shipping or if the CoA shows a purity below 97%, the customer receives a full refund or a replacement at no cost. In 2024, only 0.8% of orders resulted in a refund request, and all were processed within 5 business days.